dihydroxyphenylalanine has been researched along with adenosine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myers, S; Pugsley, TA | 1 |
| Ceccato, S; Passeri, M | 1 |
| Lipinski, J; Matthysse, S; Shih, V | 1 |
| Berezo, MW; Erny, RE; Perlman, RL | 1 |
| Erny, R; Wagner, JA | 1 |
| Galloway, MP; Roth, RH | 1 |
| Kikuchi, A; Kobayashi, J; Okano, T; Sakai, K | 1 |
| Chung, D; Han, NS; Husni, A; Jeon, JS; Um, BH | 1 |
| Korenstein, R; Madi, L; Nyska, A; Rosenberg-Haggen, B | 1 |
9 other study(ies) available for dihydroxyphenylalanine and adenosine
| Article | Year |
|---|---|
Decrease in rat striatal dopamine synthesis and metabolism in vivo by metabolically stable adenosine receptor agonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Injections, Intraperitoneal; Male; Neurons; Phenylisopropyladenosine; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic | 1986 |
[Significance of transmethylation and S-adenosylmethionine (SAM) in the management of Parkinson's disease with L-dopa].
Topics: Adenosine; Aged; Brain; Digestive System; Dihydroxyphenylalanine; Feeding and Eating Disorders; Female; Gastrointestinal Diseases; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney; Male; Methionine; Methylation; Nausea; Parkinson Disease; S-Adenosylmethionine; Vomiting | 1972 |
L-dopa and S-adenosylmethionine.
Topics: Adenosine; Carbon Isotopes; Dihydroxyphenylalanine; Humans; Methionine; Parkinson Disease; S-Adenosylmethionine; Time Factors; Tritium | 1971 |
Activation of tyrosine 3-monooxygenase in pheochromocytoma cells by adenosine.
Topics: 2-Chloroadenosine; Adenosine; Adrenal Gland Neoplasms; Calcium; Cholera Toxin; Cyclic AMP; Dihydroxyphenylalanine; Enzyme Activation; Humans; Kinetics; Norepinephrine; Pheochromocytoma; Tyrosine 3-Monooxygenase | 1981 |
Adenosine-dependent activation of tyrosine hydroxylase is defective in adenosine kinase-deficient PC12 cells.
Topics: Adenosine; Adenosine Kinase; Animals; Cells, Cultured; Cholera Toxin; Cyclic AMP; Dihydroxyphenylalanine; Enzyme Activation; Mice; Phenylisopropyladenosine; Pheochromocytoma; Phosphotransferases; Tyrosine 3-Monooxygenase | 1984 |
Neuropharmacology of 3-isobutylmethylxanthine: effects on central noradrenergic systems in vivo.
Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; Adenosine; Animals; Axons; Brain; Clonidine; Diazepam; Dihydroxyphenylalanine; Hydroxylation; Male; Methoxyhydroxyphenylglycol; Neurons; Norepinephrine; Rats; Rats, Inbred Strains; Stimulation, Chemical; Theophylline; Tyrosine 3-Monooxygenase; Yohimbine | 1983 |
Aqueous chromatography utilizing pH-/temperature-responsive polymer stationary phases to separate ionic bioactive compounds.
Topics: Acrylic Resins; Adenosine; Catecholamines; Chromatography, High Pressure Liquid; Cortisone; Dihydroxyphenylalanine; Dopamine; Epinephrine; Hydrogels; Hydrogen-Ion Concentration; Molecular Structure; Polymers; Prednisolone; Silicates; Temperature; Tyramine | 2001 |
Tyrosinase inhibition by water and ethanol extracts of a far eastern sea cucumber, Stichopus japonicus.
Topics: Adenosine; Agaricales; Animals; Biological Products; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Enzyme Inhibitors; Glucosides; Indolequinones; Inhibitory Concentration 50; Monophenol Monooxygenase; Stichopus | 2011 |
Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
Topics: Adenosine; Androstadienes; Cell Line, Tumor; Cyclic AMP; Dihydroxyphenylalanine; Humans; In Vitro Techniques; Keratinocytes; MAP Kinase Signaling System; Melanoma, Experimental; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphatidylinositol 3-Kinases; Phosphorylation; Pigmentation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A3; Skin; Skin Neoplasms; Wortmannin | 2013 |